Edesa Biotech

+$0.04 (+2.30%) As of 1:22 PM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Edesa Biotech and other ETFs, options, and stocks.

About EDSA

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquiring, developing and commercializing clinical stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its product candidate, EB01 is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis, a common, potentially debilitating condition and occupational illness.

CEO

Pardeep Nijhawan

Employees

Headquarters

Markham, Ontario

Founded

2007

EDSA Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

59.49K

High today

$1.83

Low today

$1.70

Open price

$1.74

Volume

63.05K

52 Week high

$12.00

52 Week low

$1.70

EDSA News

BenzingaMay 24

Edesa Biotech Adds Mechanically Ventilated Patients To Late-Stage COVID-19 Study

by Edesa Biotech Inc EDSA has initiated enrollment for the second cohort of patients for the Phase 3 part of a Phase 2/3 study of the company's critical care d

EDSA Earnings

-$0.37

-$0.25

-$0.12

$0.00

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

— per share

Actual

-$0.33 per share